Point-of-Care (POC) Coagulation Testing Devices Market Trends, Drivers, and Regional Analysis 2025–2029
Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care (poc) coagulation testing devices market from 2025–2034 with trusted insights from The Business Research Company
How Is The Point-of-Care (POC) Coagulation Testing Devices Market Size Expected To Expand Over 2029-2034?
The point-of-care (poc) coagulation testing devices market size has demonstrated robust growth in recent years. It is anticipated to increase from $2.12 billion in 2024 to $2.32 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.8%. This expansion during the historic period can be attributed to the rising prevalence of infectious and chronic diseases, an increasing geriatric population, the growing utilization of miniaturized portable instruments, the expanding use of biomarker profiling, and the escalating demand for personalized medicine.
The market size for point-of-care (poc) coagulation testing devices is anticipated to show significant expansion over the next few years, projected to reach $3.27 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.0%. This growth during the forecast period is fueled by an increasing demand for rapid and accurate disease diagnosis, a stronger emphasis on wellness and preventive healthcare, the rising need for quick and on-site diagnostic testing, an increase in infectious disease outbreaks, and the emergence of telemedicine. Prominent trends for this period include the integration of next-generation sequencing (NGS), RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), along with artificial intelligence (AI) and data analytics.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
Which Market Factors Are Fueling The Point-of-Care (POC) Coagulation Testing Devices Industry Growth?
The increasing occurrence of blood clotting conditions is anticipated to propel the expansion of the point-of-care (POC) coagulation testing devices market in the future. These disorders hinder the blood’s normal clotting mechanism. Certain lifestyle elements, such as smoking, heavy alcohol intake, and insufficient physical activity, can contribute to these conditions. Such habits may negatively impact blood vessel integrity, levels of clotting factors, and circulation, thereby elevating the likelihood of unusual clot development. With POC coagulation testing devices, medical professionals can rapidly evaluate a patient’s coagulation state, facilitating prompt modifications to drug dosages and therapy strategies. For instance, in October 2023, according to the annual global survey conducted by the World Federation of Hemophilia, a Canada-based international non-profit organization, in 2022, there were 427,685 individuals affected by bleeding disorders, there are 257,146 people with hemophilia, including 208,957 with Hemophilia A, 42,203 with Hemophilia B, and 5,986 with an unknown type of hemophilia. Additionally, 70,034 people have other bleeding disorders. Consequently, the growing incidence of blood clotting conditions is a key factor boosting the expansion of the point-of-care (POC) coagulation testing devices market.
Which Categories Are Covered In The Point-of-Care (POC) Coagulation Testing Devices Market Segmentation Analysis?
The point-of-care (poc) coagulation testing devicesmarket covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
What Current And Upcoming Trends Are Shaping The Point-of-Care (POC) Coagulation Testing Devices Market?
Within the point-of-care (POC) coagulation testing devices market, major companies are developing immunofluorescence-based quantitative analyzers to enhance the diagnosis and management of coagulation disorders. These analyzers are diagnostic instruments utilized in laboratory environments to accurately measure and quantify specific proteins or molecules involved in the coagulation process, thereby assisting in the identification and treatment of blood clotting conditions. As an illustration, in January 2023, Cipla Limited, an India-based pharmaceutical company, launched Cippoint. This immunofluorescence-based quantitative analyzer employs immunofluorescence technology to deliver quick and precise test results in 3 to 15 minutes, facilitating faster clinical decision-making processes. Cippoint, with its user-friendly interface, rapid turnaround time, and comprehensive testing features, is instrumental in boosting diagnostic efficiency, enabling timely clinical judgments, and improving patient care outcomes.
Which Organizations Are At The Forefront Of The Point-of-Care (POC) Coagulation Testing Devices Market?
Major companies operating in the point-of-care (POC) coagulation testing devices market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healthcare Limited, Color Health Inc., LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd., Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.
Download The Full Report Here:
Which Geographic Areas Are Driving Strong Demand For The Point-of-Care (POC) Coagulation Testing Devices Market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Devices Market 2025, By The Business Research Company
Hospital Acquired Infections Testing Kits Global Market Report 2025
Pharma Microbiology Testing Kits Global Market Report 2025
Non Invasive Prenatal Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
